Abate Kristin 4
4 · Karyopharm Therapeutics Inc. · Filed Oct 16, 2025
Insider Transaction Report
Form 4
Abate Kristin
Chief Accounting Officer
Transactions
- Award
Common Stock
2025-10-15+12,799→ 22,845 total
Footnotes (1)
- [F1]Represents the award of restricted stock units ("RSUs") pursuant to the Karyopharm Therapeutics Inc. 2022 Equity Incentive Plan, as amended. RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest as follows: 2,799 RSUs vest in two equal annual installments beginning October 31, 2026, and 10,000 RSUs vest 100% on October 15, 2026.